Zota Health Care Limited
NSE: ZOTA · Other · sector
₹1,195.20NSE close 2026-10-26
Key numbers
Market cap₹4,139 cr
Price₹1,195.20
52w high / low₹1,740 / ₹1,022
P/E–Sector median 14.4x
P/B6.0xSector median 1.7x
Book value₹200.2
Dividend yield0.07%Sector median 0.37%
ROE-22.5%Sector median 13.8%
ROCE-12.4%Sector median 19.6%
OPM-0.5%Sector median 10.4%
Debt / equity0.04xSector median 0.29x
EV/EBITDA–Sector median 8.4x
Interest cover-4.4x
Current ratio1.93x
Sales growth 3y+56.7%Sector median +7.7%
Profit growth 3y–Sector median +16.6%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹96 cr vs borrowings ₹29 cr (FY26): cash is higher (net cash).
- Operating profit covered interest -4.4x in the last 12 months.
- 0.26% of the promoters' shares are pledged (0.1% of all shares).
- Promoter holding fell by 6.43 percentage points in a year, to 49.38% (2026-09-30).
- Operating cash flow was below net profit in 1 of the last 5 years (FY26).
- Net loss in 8 of the last 8 quarters.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹1,195.20 on 2026-10-26: -31.3% from the 52-week high, +16.9% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,654.50 · low ₹547.80
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 67 | 72 | 97 | 104 | 129 | 143 | 163 | 174 |
| EBITDA | -1 | -6 | 2 | 4 | 6 | -0 | 3 | -12 |
| OPM % | -1.3% | -8.4% | 2.5% | 3.8% | 4.9% | -0.3% | 1.7% | -6.7% |
| Other income | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 |
| Net profit | -12 | -19 | -13 | -14 | -16 | -30 | -14 | -44 |
| EPS (₹) | -4.57 | -6.80 | -4.57 | -4.92 | -5.26 | -9.44 | -4.13 | -12.58 |
| Revenue YoY | +91.7% | +98.2% | +67.8% | +67.6% | ||||
| Profit YoY | – | – | – | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 131 | 140 | 180 | 293 | 539 | 609 |
| EBITDA | 15 | 8 | 8 | -6 | 13 | -3 |
| Net profit | 9 | -6 | -14 | -56 | -74 | -103 |
| EPS (₹) | 3.58 | -2.29 | -5.59 | -20.68 | -22.46 | -31.41 |
| Revenue growth | +6.7% | +29.0% | +62.3% | +83.9% | +78.9% | |
| Profit growth | -164.8% | – | – | – | – | |
| Dividend / share (₹) | 1.00 | 1.50 | 1.00 | 1.00 | 1.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +56.7% | +38.2% | +78.9% |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +46.4% (2y) | -18.4% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 80 | 90 | 224 | 693 |
| Borrowings | – | 9 | 15 | 6 | 29 |
| Cash & equivalents | – | 1 | 1 | 4 | 96 |
| Total assets | – | 158 | 228 | 439 | 1,131 |
| Fixed assets | – | 15 | 24 | 56 | 140 |
| Capital work in progress | – | 3 | 5 | 6 | 2 |
| Investments | – | 8 | 5 | 54 | 264 |
| Receivables | – | 28 | 27 | 40 | 74 |
| Inventory | – | 42 | 54 | 106 | 193 |
| Payables | – | 26 | 34 | 42 | 105 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 13 | -2 | -6 | -50 | -84 |
| Cash from investing | -27 | 15 | -13 | -92 | -314 |
| Cash from financing | 14 | -14 | 19 | 145 | 490 |
| Capex | 3 | 12 | 0 | 0 | 0 |
| Free cash flow | 10 | -15 | -6 | -50 | -84 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | -7.2% | -15.9% | -25.2% | -10.7% |
| ROCE % | – | -2.4% | -10.9% | -20.4% | -8.7% |
| Debtor days | – | 73 | 55 | 50 | 50 |
| Inventory days | – | 183 | 203 | 281 | 329 |
| Payable days | – | 116 | 127 | 113 | 178 |
| Cash conversion cycle (days) | – | 140 | 131 | 218 | 201 |
| Working capital days | – | 114 | 77 | 104 | 149 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 49.38% |
| FIIs | 6.92% |
| DIIs | 7.30% |
| of which Mutual funds | 0.37% |
| of which Insurance | 0.00% |
| Government | 0.00% |
| Public (non-institutions) | 36.40% |
| Quarter | Apr 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 58.11% | 57.42% | 55.81% | 51.56% | 50.64% | 49.38% | 49.38% | 49.38% |
| Promoter group | % |
|---|---|
| Himansubhai Muktilal Zota | 9.05% |
| Ketankumar Chandulal Zota | 8.81% |
| Manukant Chandulal Zota | 6.27% |
| Kamlesh Rajanikant Zota | 5.75% |
| Manishaben Kamleshkumar Zota | 4.14% |
| Rasilaben Manukantbhai Zota | 2.89% |
| Zota Ketankumar Chandulal | 2.83% |
| Varshaben Himanshubhai Zota | 2.60% |
| Anilaben Ketankumar Zota | 2.22% |
| Viren Manukant Zota | 1.47% |
| Moxesh Ketanbhai Zota | 1.43% |
| Zota Manukant Chandulal HUF (Karta - Zota Manukant Chandulal) | 0.60% |
| Dhara Mehta | 0.40% |
| Kenvi Megh Gandhi | 0.27% |
| Kinjal Nikesh Mehta | 0.15% |
| Public holders above 1% | % |
|---|---|
| Asha Mukul Agrawal | 5.14% |
| Valiant Mauritius Partners Offshore Limited | 2.74% |
| Mukul Mahavir Agrawal | 2.13% |
| Singularity Equity Fund I | 2.02% |
| Jainam Broking Limited | 1.48% |
| Lyptus Punch Card Fund | 1.41% |
| Valiant Mauritius Partners Limited | 1.41% |
| 3P India Equity Fund 1 | 1.13% |
14,928 shareholders. Pledged: 0.26% of promoter shares.
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| SAKAR | ₹2,160 cr | 59.9x | 6.7x | 11.8% | 14.8% | 28.5% | +23.6% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-21 | Dividend | Dividend - Re 1 Per Share |
| 2025-09-22 | Dividend | Dividend - Re 1 Per Share |
| 2024-09-20 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 2023-09-22 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 2022-09-19 | Dividend | Annual General Meeting/Dividend - Rs 1.50 Per Share |
| 2021-09-22 | Dividend | Annual General Meeting/ Dividend Rs 1 Per Share |
| 2020-09-17 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 2019-09-12 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
Links go to the original files on the exchange website.
About the company
- Pharmaceutical: Manufacturing & Marketing of Pharmaceutical products
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | ZOTA |
| BSE code | – |
| ISIN | INE358U01012 |
| Face value | ₹10.0 |
| Incorporated | 2000-07-12 |
| Website | www.zotahealthcare.com |
| Plants (India / abroad) | 1 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.